Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

127.00p
   
  • Change Today:
      0.50p
  • 52 Week High: 139.50p
  • 52 Week Low: 96.00p
  • Currency: UK Pounds
  • Shares Issued: 104.77m
  • Volume: 75,554
  • Market Cap: £133.06m
  • RiskGrade: 95

Latest ShareCast News

Cello Health reports positive momentum as it works on US market

By Josh White

Date: Wednesday 18 Sep 2019

(Sharecast News) - Healthcare-focussed advisory firm Cello Health reported a 6.8% improvement in net revenue to £54.5m in its half-year results on Wednesday, with its like-for-like constant currency net revenue growth standing at 4.5%.

Cello Health Regulatory News

Interim Results 18-Sep-2019 07:00 RNS
Holding(s) in Company 23-Aug-2019 10:40 RNS
Acquisition of ISS 16-Aug-2019 07:00 RNS
Total Voting Rights 06-Aug-2019 15:07 RNS
Notification of Half Year Results 06-Aug-2019 07:00 RNS

Cello Health News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cello Health Market Data

Currency UK Pounds
Share Price 127.00p
Change Today 0.50p
% Change 0.40 %
52 Week High 139.50p
52 Week Low 96.00p
Volume 75,554
Shares Issued 104.77m
Market Cap £133.06m
RiskGrade 95

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
67.63% below the market average67.63% below the market average67.63% below the market average67.63% below the market average67.63% below the market average
48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average
Price Trend
9.70% above the market average9.70% above the market average9.70% above the market average9.70% above the market average9.70% above the market average
15.00% above the sector average15.00% above the sector average15.00% above the sector average15.00% above the sector average15.00% above the sector average
Income
10.57% above the market average10.57% above the market average10.57% above the market average10.57% above the market average10.57% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Growth
32.64% below the market average32.64% below the market average32.64% below the market average32.64% below the market average32.64% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  Interim Final
Ex-Div 03-Oct-19 25-Apr-19
Paid 01-Nov-19 24-May-19
Amount 1.15p 2.75p

Trades for 20-Sep-2019

Time Volume / Share Price
17:07 3,000 @ 127.00p
16:00 6,300 @ 126.50p
15:58 3,000 @ 127.28p
15:54 3,939 @ 126.92p
15:33 3,500 @ 126.92p

Cello Health Key Personnel

CEO Mark Scott

Top of Page